The American Red Cross is calling for blood donors, offering A1C diabetes tests and a $15 Amazon gift card to help support ...

Eli Lilly has spent months signaling it would challenge Novo Nordisk’s oral GLP-1 franchise. Now it has data to back that up.

A nationwide blood shortage, worsened by a snowy and cold winter, has prompted the Red Cross to offer incentives to encourage ...

Feb. 26, 2026 (San Diego County) -- The American Red Cross is turning a routine blood donation into a lifesaving health diagnostic in March. The move comes as new data reveals a startling trend: 1 in ...

New data from the American Red Cross shows that 1 in 5 blood donors has A1C levels in the prediabetic or diabetic range. In recognition of American Heart Month, the health system’s mobile clinic will ...

New data from the American Red Cross shows that 1 in 5 blood donors has A1C levels in the prediabetic or diabetic range.

Looking to donate blood? Join the 6abc Philly Blood Drive on March 25, 2026, at five locations in Pennsylvania and New Jersey.

Eli Lilly shares rise after orforglipron beats Novo's drug in Phase 3, cutting A1C by 2.2% and boosting weight loss results.

The American Red Cross is still urging donors to help the national blood supply recover from a severe blood shortage. As a thank-you, successful donations will receive free A1C testing, commonly used ...

The American Red Cross is seeking blood donors and offering medical testing as an incentive to donate. The organization “urges donors to help the national blood supply recover from a severe blood ...

Novo Nordisk reported a loss in a head-to-head trial of CagriSema against Lilly’s Zepbound earlier this week. This time around, Lilly's orforglipron bested Novo's oral Wegovy in blood sugar control ...